Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ismaeel Yunusa

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Clinical Pharmacology|October 20, 2020
Second-generation antipsychotics and pregnancy complications: the impact of confounding by indicationOlorunfemi A Oshagbemi, Abraham Daniel, Ismaeel Yunusa
Journal of Alzheimer'S Disease Reports|November 10, 2021
Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer's Disease in the United States: A Cost-Effectiveness AnalysisIsmaeel Yunusa, Saud Alsahali, Amey Rane, et al.
Frontiers in Pharmacology|March 17, 2020
Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related PsychosisIsmaeel Yunusa, Marie Line El Helou, Saud Alsahali
JMIR Public Health and Surveillance|June 3, 2021
The Influence of COVID-19 Information Sources on the Attitudes and Practices Toward COVID-19 Among the General Public of Saudi Arabia: Cross-sectional Online Survey StudyNoor Alshareef, Ismaeel Yunusa, Mohammed Khaled Al-Hanawi
Lung Cancer Management|December 15, 2020
Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysisAbdullah Alanazi, Ismaeel Yunusa, Khaled Elenizi, et al.
Lancet Regional Health. Americas|March 13, 2023
Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug developmentRouen Brockmann, Joanna Nixon, Bryan L Love, et al.
JAMA Network Open|February 24, 2022
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake InhibitorsIsmaeel Yunusa, Joshua J Gagne, Kazuki Yoshida, et al.
JAMA Network Open|July 28, 2023
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020Ibraheem M Karaye, Nasim Maleki, Nawaal Hassan, et al.
Pharmacoepidemiology and Drug Safety|April 15, 2022
Applying mixture cure survival modeling to medication persistence analysisChao Cai, Bryan L Love, Ismaeel Yunusa, et al.
Journal of Geriatric Psychiatry and Neurology|January 31, 2023
Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson's Disease Psychosis: Systematic Review and Network Meta-AnalysisIsmaeel Yunusa, Nazia Rashid, Roxanna Seyedin, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Clinical Pharmacology|October 20, 2020
Second-generation antipsychotics and pregnancy complications: the impact of confounding by indicationOlorunfemi A Oshagbemi, Abraham Daniel, Ismaeel Yunusa
Journal of Alzheimer'S Disease Reports|November 10, 2021
Comparative Value of Cholinesterase Inhibitors and Memantine in Persons with Moderate-to-Severe Alzheimer's Disease in the United States: A Cost-Effectiveness AnalysisIsmaeel Yunusa, Saud Alsahali, Amey Rane, et al.
Frontiers in Pharmacology|March 17, 2020
Pimavanserin: A Novel Antipsychotic With Potentials to Address an Unmet Need of Older Adults With Dementia-Related PsychosisIsmaeel Yunusa, Marie Line El Helou, Saud Alsahali
JMIR Public Health and Surveillance|June 3, 2021
The Influence of COVID-19 Information Sources on the Attitudes and Practices Toward COVID-19 Among the General Public of Saudi Arabia: Cross-sectional Online Survey StudyNoor Alshareef, Ismaeel Yunusa, Mohammed Khaled Al-Hanawi
Lung Cancer Management|December 15, 2020
Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysisAbdullah Alanazi, Ismaeel Yunusa, Khaled Elenizi, et al.
Lancet Regional Health. Americas|March 13, 2023
Impacts of FDA approval and Medicare restriction on antiamyloid therapies for Alzheimer's disease: patient outcomes, healthcare costs, and drug developmentRouen Brockmann, Joanna Nixon, Bryan L Love, et al.
JAMA Network Open|February 24, 2022
Risk of Opioid Overdose Associated With Concomitant Use of Oxycodone and Selective Serotonin Reuptake InhibitorsIsmaeel Yunusa, Joshua J Gagne, Kazuki Yoshida, et al.
JAMA Network Open|July 28, 2023
Trends in Alcohol-Related Deaths by Sex in the US, 1999-2020Ibraheem M Karaye, Nasim Maleki, Nawaal Hassan, et al.
Pharmacoepidemiology and Drug Safety|April 15, 2022
Applying mixture cure survival modeling to medication persistence analysisChao Cai, Bryan L Love, Ismaeel Yunusa, et al.
Journal of Geriatric Psychiatry and Neurology|January 31, 2023
Comparative Efficacy, Safety, and Acceptability of Pimavanserin and Other Atypical Antipsychotics for Parkinson's Disease Psychosis: Systematic Review and Network Meta-AnalysisIsmaeel Yunusa, Nazia Rashid, Roxanna Seyedin, et al.
Pageof 8